risk of medullary thyroid cancer with glp 1 GLP-1 Receptor Agonists and Risk, Rodent Data and FDA Warning, • In rodents, GLP-1 receptor agonists (GLP-1 RAs) stimulate thyroid C-cells, increasing the incidence thyroid Do GLP-1 Medications Increase Thyroid

As pharmacological interventions demonstrate robust efficacy, obesity is increasingly recognized as a medical condition warranting comprehensive treatment, akin to other chronic diseases

Follow the instructions below to get started

In one study, microdosing GLP-1s supported moderate weight loss of up to 10 pounds over 40 weeks in participants. MICRODOSING GLP-1 BENEFITS Do More, Age Less Modulated inflammatory pathways in clinical trials. Studies found a reduced risk of cognitive decline Supported cardiovascular health in clinical trials Improved mitochondrial function and oxidative stress in clinical trials Low doses reduced side effects in clinical trials Supported moderate weight loss of up to 10 pounds over 40 weeks in one study *See studies cited below

kidney routes), their excretion, their elimination half-life, their target selectivity, and their effective dosage [46]

Wai KM, et al